Multiple Sclerosis: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 1,529 matching trials) · https://research.opensourcemed.info/briefs/multiple-sclerosis.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- Interferon beta-1b (Betaseron, BAY86-5046) 4 trials
- Rebif® 2 trials
- ACTH (see NCT02315872) 1 trial
- Anti-Mullerian hormone (AMH) level 1 trial
- Cetrizine 1 trial
- Diphenhydramine 1 trial
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Transcranial brain stimulation (tDCS, TMS) 43 trials · 16 completed · 11 with results
- Aerobic and endurance exercise 60 trials · 28 completed · 4 with results
- Education, coaching and self-management 35 trials · 19 completed · 3 with results
- Mindfulness, meditation and relaxation 17 trials · 8 completed · 3 with results
- Psychotherapy, counselling and peer support 20 trials · 10 completed · 2 with results
- Cognitive behavioural and related therapies 16 trials · 9 completed · 2 with results
Natural products (RepurpOS Moderate tier)
Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.
- Ginkgo Biloba
- Vitamin D3
- Melatonin
- Coenzyme Q10
- L-Carnitine
- Cannabidiol (CBD)
Biomarkers reported
Direction in patients compared with the stated comparison group, as reported in the cited study.
- 25-Hydroxyvitamin D lower · Clarke et al. 2020
- CSF IgG Index higher · Saadeh et al. 2022
- CSF Kappa Free Light Chains higher · Vecchio et al. 2024
- CSF Oligoclonal Bands higher · Mukherjee et al. 2025
- GFAP higher · Chitnis et al. 2025
- Neurofilament Light Chain (NfL) higher · Chitnis et al. 2025
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function… NCT06675955
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis NCT07067463
- Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared… NCT05754593
- Clinical Applications of Advanced Ophthalmic Imaging NCT03135327
- Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis NCT06441617
- Montpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using… NCT05962177
What we don't know yet
Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.
- Exercise and physical activity: symptom severity and disease activity 26 trials, no results posted yet
- Rehabilitation and therapy services: cognition 22 trials, no results posted yet